Annexon, Inc.
(ANNX - NASDAQ)
6,10 USD
📋 Profilo Aziendale

Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders.

|